Lotus Eye Hospital and Institute Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Lotus Eye Hospital and Institute Limited generated cash of $56,834,000, which is more than the previous year. Cash used in financing activities reached the amount of -$34,018,000 last year. Net change in cash is therefore -$23,511,000.
Cash Flow
| 2012 | 22.82M | -32.89M | 1.46M |
|---|---|---|---|
| 2016 | 33.42M | -8.47M | -5.37M |
| 2018 | 57.78M | -38.60M | -15.06M |
| 2020 | 48.14M | -5.25M | 1.34M |
| 2021 | 27.39M | 4.85M | -3.27M |
| 2023 | 43.87M | -21.94M | -17.05M |
| 2024 | 56.83M | -46.32M | -34.01M |
LOTUSEYE.NS Cash Flow Statement (2012 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 92.80M | 87.93M | 69.95M | 25.92M | 34.01M | 5.15M | 8.35M |
Operating activities | |||||||
Net income | 29.14M | 56.53M | 19.11M | 21.47M | 16.60M | -205K | -21.70M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 37.27M | 29.80M | 23.30M | 24.96M | 33.71M | 44.34M | 39.98M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | -857K | -5.47M | -809K | 1.03M | -6.03M | -1.56M | 0 |
Inventories | -4.21M | -4.85M | 3.33M | 425K | -5.90M | 3.04M | -4.36M |
Accounts payable | 3.83M | -4.11M | -624K | 2.45M | 13.14M | 0 | 0 |
Cash generated by operating activities | 56.83M | 43.87M | 27.39M | 48.14M | 57.78M | 33.42M | 22.82M |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -56.43M | -30.97M | -4.75M | -24.20M | -42.76M | -11.51M | -33.81M |
Acquisitions Net | 0 | 92K | 3.55M | 9.94M | 765K | 464K | 0 |
Cash generated by investing activities | -46.32M | -21.94M | 4.85M | -5.25M | -38.60M | -8.47M | -32.89M |
Financing activities | |||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -10.39M | -10.39M | 0 | 0 | -12.51M | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -22.64M | -5.67M | -2.62M | 2.05M | -2.01M | -1.87M | 0 |
Cash used in financing activities | -34.01M | -17.05M | -3.27M | 1.34M | -15.06M | -5.37M | 1.46M |
Net Change In Cash | -23.51M | 4.87M | 28.96M | 44.23M | 4.10M | 19.58M | -8.61M |
Cash at end of period | 69.29M | 92.80M | 98.92M | 70.16M | 38.12M | 24.73M | -259K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |